Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Mid Cap Fund median (34 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 25 Feb 2014 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Motilal Oswal Midcap Fund |
|---|---|
| 25 Feb 2014 | ₹100.00 |
| 12 Mar 2015 | ₹204.69 |
| 26 Mar 2016 | ₹194.28 |
| 10 Apr 2017 | ₹264.42 |
| 25 Apr 2018 | ₹273.87 |
| 10 May 2019 | ₹258.49 |
| 24 May 2020 | ₹208.92 |
| 07 Jun 2021 | ₹385.28 |
| 22 Jun 2022 | ₹447.43 |
| 07 Jul 2023 | ₹651.79 |
| 21 Jul 2024 | ₹1091.94 |
| 05 Aug 2025 | ₹1175.82 |
| 20 Aug 2026 | ₹1214.47 |
| Metric | Motilal Oswal · Direct NAV ₹121.62 Very High risk ★★★☆☆ | Category median Mid Cap Fund · 34 funds |
|---|---|---|
| +1.85% | +9.87% | |
| +22.57% | +19.74% | |
| +24.04% | +17.84% | |
| +18.10% | +17.01% | |
| +22.15% | +19.29% | |
| +20.03% | — | |
| +20.53% | +20.53% | |
| +19.58% | +19.07% | |
| +20.02% | +18.49% | |
| Risk | ||
| 17.82% | 16.20% | |
| 0.90 | 0.83 | |
| 1.29 | 1.14 | |
| -37.23% | -32.95% | |
| Nifty Midcap 150 | — | |
| +3.92% | +2.33% | |
| 0.95 | 0.94 | |
| 104.1% | 98.4% | |
| 91.1% | 87.8% | |
| 0.93% | 0.97% | |
| ₹36,069Cr | ₹7,594Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 35% | 40% | |
| Rakesh Shetty | — | |
| 25 Feb 2014 | — | |
| 29 | — | |
| 53.3% | — | |
| 2.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.